Table 2.
Patient number | Interim (yr) | LH (IU/liter)
|
T (ng/dl)
|
FSH (IU/liter)
|
Inhibin B (pg/ml)
|
Sperm count (×106/ml)
|
|||||
---|---|---|---|---|---|---|---|---|---|---|---|
BL | FU | BL | FU | BL | FU | BL | FU | BL | FU | ||
1 | 4 | 12.5 | 6.2 | 83 | 69 | 14.2 | 8.6 | 43 | 12 | 0 | 0 |
2 | 4 | 2.1 | 2.2 | 21 | 10 | 1.6 | 1.6 | 160 | 183 | 0 | 0 |
3a | 8 | <1.6 | 3.6 | 100 | 21 | 2.2 | 2.4 | 147 | 134 | X | <1 |
4a | 8 | 1.8 | 9.3 | 84 | 112 | 4.9 | 8.6 | 60 | 32 | X | X |
5a | 9 | 4.3 | 3.4 | 129 | 41 | 4.9 | 4.1 | 124 | 51 | X | X |
6 | 9 | 4.8 | 5.1 | 122 | 123 | 3.2 | 4.0 | 189 | 168 | <1 | <1 |
7a | 11 | <1.6 | 3.5 | 106 | 68 | 2.9 | 3.6 | 114 | 85 | X | 84 |
8a | 12 | <1.6 | <1.6 | 118 | 16 | 1.9 | 1.7 | 63 | 73 | 0 | 0 |
9a | 19 | 1.6 | 2.9 | 63 | 106 | 1.8 | 1.8 | 228 | 266 | 0 | X |
10a | 22 | <1.6 | <1.6 | 45 | 9 | <1.6 | <1.6 | 80 | 66 | 0 | 0 |
Mean ± sem | 10.6 ± 5.9 | 2.3 ± 0.4 | 3.9 ± 0.8 | 84 ± 12 | 58 ± 14 | 2.8 ± 0.4 | 3.8 ± 0.9 | 121 ± 19 | 118 ± 25 |
Baseline evaluation has been reported previously (5).
BL, Baseline at diagnosis; FU, long-term follow up; X, subject unable to provide specimen.